Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Opinion
Video
Medifocus FDA Approved, In-office Treatment Of...
Medifocus FDA Approved, In-office Treatment Of Enlarged Prostate
BTV-Business Television
, www.b-tv.com
0 Comments
|
April 1, 2014
{{labelSign}} Favorites
{{errorMessage}}
BTV highlights their FDA approved minimally invasive in-office treatment for the symptoms of enlarged prostate in men.
Symbol:
V.MFS
Tags:
BIOTECHNOLOGY
BIOTECHNOLOGY-15840
{{labelSign}} Favorites
{{errorMessage}}
Related
@ the Bell: TSX ends week reaching another fresh high
1 day ago
@ the Bell: TSX blows past all-time high
2 days ago
@ the Bell: Heavyweight sectors keep TSX flat
3 days ago
Featured Company
Tribe Property Technologies Inc.
V.TRBE
Tribe Property Technologies Inc. is a property technology company. The Company offers technology-enabled property management ...
view more »